The New Delhi-based All India Institute of Medical Sciences (AIIMS) has reported its first coronavirus disease (Covid-19)-induced brain nerve damage in a girl (11), which has led to her blurred vision.
According to a report by Hindustan Times, AIIMS reported its first Coronavirus disease (Covid-19)-induced brain nerve damage in an 11-year-old girl.
“We have found Covid-19 infection-induced Acute Demyelinating Syndrome (ADS) in an 11-year-old girl. This is the first case that has been reported in the paediatric age group,” said the draft of the report.
A protective layer called myelin covers the nerves that helps messages from the brain move quickly and smoothly through the body. ADS include health conditions that damage myelin, brain signals and affect neurological functions.
“This girl had come to us with a loss of vision. The MRI (magnetic resonance imaging) showed ADS, which is a new manifestation. However, we now know that the virus majorly affects the brain and the lungs. We plan to publish this case report since we have established that her condition was Covid-19 induced,” Dr Sheffali Gulati of the department of paediatrics at All India Institute of Medical Science (AIIMS) was quoted as saying in the report.
AIIMS authorities are also treating another Covid-19 positive teenager (13) girl after she had complained of fever and encephalopathy (swelling of brain). She is undergoing treatment and the doctors are still trying to ascertain whether her condition was induced by Covid-19.
Epilepsy, encephalitis, Kawasaki-like disease, Guillain-barre syndrome etc are the other commonplace health complications that children, who tested Covid-19 positive, are known to suffer from.
In a review published in the journal Pediatric Neurology, Dr Gulati, said, “…the challenges faced by paediatric neurologists in a developing country are distinctive. Only a few centres, including ours, run round-the-clock child neurology tele-helpline and tele-consultation services, but restricted availability of video-calls and internet facility at rural households limits their efficient use. Besides, specialised facilities such as dietary therapy and surgery for drug-refractory epilepsy, etc. are offered at only a few centres only.”
The treatment gap for neurological disorders is going to increase in India in the near future.